International Journal of Gynecology & Obstetrics
Volume 93, Issue 2 , Pages 140-141 , May 2006

High-dose dexamethasone in the treatment of HELLP syndrome

  • S. Mould
  • ,
  • F. Paruk
  • ,
  • J. Moodley

      Affiliations

    • Corresponding Author InformationCorresponding author. Women's Health and HIV Research Group, Nelson R Mandela School of Medicine, Private Bag 7, Congella, 4013, South Africa. Tel./fax: +27 031 2604241.

Received 27 September 2005 ,Revised 16 January 2006 ,Accepted 17 January 2006.

References 

  1. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal–perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe pre-eclampsia/eclampsia. Am J Obstet Gynecol. 1986;155:501–509
  2. Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP syndrome. Am J Obstet Gynecol. 1997;177:1011–1017
  3. Fonseca JE, Mendez F, Cantano C. Dexamethasone treatment does not improve the outcome of women with the HELLP syndrome: a double-blind placebo-controlled randomised clinical trial. Am J Obstet Gynecol. 2005;193:1591–1598

PII: S0020-7292(06)00025-7

doi: 10.1016/j.ijgo.2006.01.017

International Journal of Gynecology & Obstetrics
Volume 93, Issue 2 , Pages 140-141 , May 2006